#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Small cell lung cancer Angiosarcoma non-metastatic Waldenstrom's macroglobulinaemia Mucopolysaccharidosis III Mantle cell lymphoma stage IV Pseudoxanthoma elasticum Rhabdomyosarcoma recurrent Gastrointestinal stromal tumour HER2 gene amplification Gastroenteropancreatic neuroendocrine tumour disease Glomerulonephritis membranoproliferative Bulbospinal muscular atrophy congenital Chronic lymphocytic leukaemia refractory Acute graft versus host disease in liver Alveolar proteinosis More trials…

    Learn about Rare Diseases

    Paraneoplastic neurological syndrome – Basic Information Mucopolysaccharidosis – Diagnostics Hereditary motor and sensory neuropathy Von Willebrand’s disease – Diagnostics Mucous membrane pemphigoid – Life with Disease Factor VIII deficiency Shprintzen-Goldberg syndrome – Treatment Cytokine release syndrome – Trials in Disease Mucopolysaccharidosis III – Basic Information Systemic mastocytosis – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Lamotrigine Macitentan Bepirovirsen Deutivacaftor POTASSIUM CLAVULANATE Mva-209-Fsp-B1 Vinblastine Sulfate Naloxone Hydrochloride Db-1303 Pitavastatin Calcium Etavopivat Pp1493 YOHIMBINE HYDROCHLORIDE Piperacillin Sodium Itraconazole Aprepitant Crd-4730 Dog Epithelium Extract Ondansetron Hydrochloride Timothy Grass Pollen Extract More therapies…

    Learn about Your Condition

    Oral neoplasm Corneal graft rejection Meningioma Short stature Head injury Polymyalgia rheumatica Varicella Retinal artery occlusion Pre-eclampsia Cognitive disorder Chronic kidney disease Ovarian cancer metastatic Benign neoplasm of ureter Ehlers-Danlos syndrome Liposarcoma recurrent More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Evangelismos S.A.

Evangelismos S.A.

Ipsiladou 45-47, Athens, 106 76, Greece

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Early Clarithromycin Treatment to Prevent Sepsis in Patients with Community-Acquired Pneumonia

    Recruiting

    3 1 1
    Investigated Drugs:
    • Clarithromycin
    Greece

  • Long-Term Follow-Up Study for Patients Treated with CAR T-Cell Therapy Using PHE885, YTB323, and Tisagenlecleucel

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • B-cell lymphoma
    • B-cell type acute leukaemia
    • Plasma cell myeloma
    Investigated Drugs:
    • Autologous T-Cells Encoding A Chimeric Antigen Receptor Targeting Human B Cell Maturation Antigen
    • Tisagenlecleucel
    • Rapcabtagene Autoleucel
    Austria Belgium Denmark Finland France Germany +6

  • Study on Fluasterone for Managing High Blood Sugar in Adults with Cushing’s Syndrome

    Recruiting

    2 1
    Investigated Drugs:
    • Fluasterone
    Greece

  • Study Comparing Elranatamab to Drug Combinations for Patients with Relapsed/Refractory Multiple Myeloma After Anti-CD38 Therapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma refractory
    Investigated Drugs:
    • Bortezomib
    • Carfilzomib
    • Dexamethasone
    Belgium Croatia Czechia Denmark Finland France +10

  • Study Comparing Nemtabrutinib, Ibrutinib, and Acalabrutinib for Patients with Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • B-cell small lymphocytic lymphoma
    • Chronic lymphocytic leukaemia
    Investigated Drugs:
    • Acalabrutinib
    • Ibrutinib
    • Nemtabrutinib
    Belgium Czechia Denmark Germany Greece Norway +4

  • Study on the Long-Term Safety of Aficamten (CK-3773274) for Patients with Symptomatic Hypertrophic Cardiomyopathy

    Recruiting

    2 1 1
    Investigated Diseases:
    • Hypertrophic cardiomyopathy
    Investigated Drugs:
    • Aficamten
    Czechia Denmark France Germany Greece Hungary +6

  • Study on Anakinra for Patients with Long COVID and Ongoing Respiratory Symptoms

    Recruiting

    4 1 1
    Investigated Diseases:
    • Post-acute COVID-19 syndrome
    Investigated Drugs:
    • Anakinra
    Germany Greece Italy Spain

  • Study Comparing Iberdomide and Lenalidomide for Maintenance Therapy After Stem Cell Transplant in Patients with Newly Diagnosed Multiple Myeloma

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Enoxaparin Sodium
    • Iberdomide
    • Warfarin Sodium
    Austria Belgium Czechia Denmark Finland France +10

  • Study of isatuximab, evorpacept and dexamethasone combination therapy for patients with relapsed or refractory multiple myeloma

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma refractory
    Investigated Drugs:
    • Isatuximab
    • Dexamethasone
    France Germany Greece Italy Norway Portugal

  • Study of isatuximab, pomalidomide and dexamethasone combination for patients with relapsed or refractory multiple myeloma

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma refractory
    Investigated Drugs:
    • Isatuximab
    • Dexamethasone
    • Pomalidomide
    France Germany Greece Italy Norway Portugal
Previous Page
1 … 3 4 5 6 7 … 14
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!